Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Filana Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Filana Therapeutics Inc. June 11, 202685.0%
-
Sarepta Therapeutics Inc. June 5, 202587.1%
-
Sarepta Therapeutics Inc. June 8, 202372.5%
-
Filana Therapeutics Inc. May 4, 202374.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 30, 2026 | Filana Therapeutics Inc. | Open-market purchase | +100,000 | $0.92 | $92,000 |
| Sep 29, 2026 | Filana Therapeutics Inc. | Open-market purchase | +206,813 | $0.90 | $186,132 |
| Sep 28, 2026 | Filana Therapeutics Inc. | Open-market purchase | +93,091 | $0.84 | $78,196 |
| Jun 4, 2026 | Sarepta Therapeutics Inc. | Grant or award | +16,875 | — | — |
| Nov 20, 2025 | Filana Therapeutics Inc. | Open-market purchase | +150,000 | $2.76 | $414,000 |
| Nov 19, 2025 | Filana Therapeutics Inc. | Open-market purchase | +73,385 | $2.75 | $201,809 |
| Sep 22, 2025 | Filana Therapeutics Inc. | Open-market purchase | +7,172 | $2.28 | $16,352 |
| Sep 19, 2025 | Filana Therapeutics Inc. | Open-market purchase | +400 | $2.25 | $900 |
| Sep 19, 2025 | Filana Therapeutics Inc. | Open-market purchase | +46,908 | $2.29 | $107,419 |
| Sep 18, 2025 | Filana Therapeutics Inc. | Open-market purchase | +5,400 | $2.13 | $11,502 |
| Sep 18, 2025 | Filana Therapeutics Inc. | Open-market purchase | +185,233 | $2.24 | $414,922 |
| May 16, 2025 | Sarepta Therapeutics Inc. | Option exercise | +12,350 | $32.63 | $402,981 |
| May 13, 2025 | Sarepta Therapeutics Inc. | Option exercise | +9,746 | $25.18 | $245,404 |
| May 13, 2025 | Sarepta Therapeutics Inc. | Option exercise | +10,500 | $13.71 | $143,955 |
| Mar 10, 2025 | Sarepta Therapeutics Inc. | Grant or award | +2,383 | — | — |
Questions about Richard Barry
What boards is Richard Barry on?
Richard Barry sits on the boards of Filana Therapeutics Inc. and Sarepta Therapeutics Inc.
What company is Richard Barry the CEO of?
Richard Barry is President & CEO of Filana Therapeutics Inc.
How long has Richard Barry served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.